iShares US Pharmaceuticals ETF
IHE
IHE
76 hedge funds and large institutions have $202M invested in iShares US Pharmaceuticals ETF in 2013 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 23 increasing their positions, 18 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
11.86% more ownership
Funds ownership: 95.09% → 106.95% (+12%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
76
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$4.84M | |
| 2 | +$3.14M | |
| 3 | +$2.74M | |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$1.91M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.85M |
Top Sellers
| 1 | -$2.96M | |
| 2 | -$2.43M | |
| 3 | -$920K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$698K |
| 5 |
SG Americas Securities
New York
|
-$669K |